Coronakoll i Region stockholm

Läs mer

Stäng meddelande
Coronakoll i Region stockholm

Läs mer

Stäng meddelande

Tvångssyndrom - Referenser

Rekommenderad litteratur

En bra handbok att rekommendera till patienter och närstående är: ”Fri från tvång” av Mia Asplund och Elin-Love Rosengren.

För klinisk tillämpning av ERP se exempelvis Om och om och om igen av Bates, S (3) eller OCD in children and adolescents: a cognitive-behavioral treatment manual av March, J S och Mulle, K (34) eller Tvångssyndrom: orsaker och behandling i beteende-terapeutiskt perspektiv av Wadström (4).


  1. Murray CJL, Lopez A D, Harvard School of Public Health, et al. . The global burden of disease : A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, Mass: Harvard University Press; 1996
  2. Menchon JM, Bobes J, Saiz-Ruiz J. Obsessive-compulsive disorder: The usefulness of a pharmacological practice guideline. Revista de psiquiatria y salud mental. 2016 Jul-Sep;9(3):131-3. PubMed PMID: 27368427. Trastorno obsesivo-compulsivo: utilidad de una guia terapeutica farmacologica.
  3. American Psychiatric Association., American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders : DSM-5. 5th ed. Washington, D.C.: American Psychiatric Publishing; 2013. xliv, 947 p. p.
  4. Bates S, Grönberg, A. Om och om och om igen – Att behandla tvångsproblem med KBT. Stockholm: Natur & Kultur; 2010.
  5. Wadström O. Tvångssyndrom: Orsaker och behandling i beteende-terapeutiskt perspektiv. Linköping: Psykologinsats; 2014.
  6. Flament MF, Koby E, Rapoport JL, Berg CJ, Zahn T, Cox C, et al. Childhood obsessive-compulsive disorder: a prospective follow-up study. J Child Psychol Psychiatry. 1990 Mar;31(3):363-80. PubMed PMID: 2318919.
  7. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]. Arch Gen Psychiatry. 1999 Feb;56(2):121-7. PubMed PMID: 10025435.
  8. Mataix-Cols D, Nakatani E, Micali N, Heyman I. Structure of obsessive-compulsive symtoms in pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2008 Jul;47(7):773-8. PubMed PMID: 18344900.
  9. Association. AP. MINI-D5, Diagnostiska kriterier enligt DSM-5. . Stockholm: Pilgrim Press; 2014.
  10. Krebs G, Heyman I. Obsessive-compulsive disorder in children and adolescents. Arch Dis Child. 2015 May;100(5):495-9. PubMed PMID: 25398447. Pubmed Central PMCID: 4413836.
  11. Psychiatry AAoCaA. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):98-113. PubMed PMID: 22176943.
  12. Volz C, Heyman I. Case series: transformation obsession in young people with obsessive-compulsive disorder (OCD). J Am Acad Child Adolesc Psychiatry. 2007 Jun;46(6):766-72. PubMed PMID: 17513989.
  13. Fontenelle LF, Cocchi, L, Harrison, B J, Miguel, E C, & Torres, A R. Role of stressful and traumatic life events in obsessive-compulsive disorder. Neuropsychiatry. 2011; 1(1):61-9.
  14. Rachman S, de Silva P. Abnormal and normal obsessions. Behav Res Ther. 1978;16(4):233-48. PubMed PMID: 718588.
  15. Ivarsson T, Melin K, Wallin L. Categorical and dimensional aspects of co-morbidity in obsessive-compulsive disorder (OCD). Eur Child Adolesc Psychiatry. 2008 Feb;17(1):20-31. PubMed PMID: 18004647.
  16. van Steensel FJ, Bogels SM, Perrin S. Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clin Child Fam Psychol Rev. 2011 Sep;14(3):302-17. PubMed PMID: 21735077. Pubmed Central PMCID: 3162631.
  17. Barton R, & Heyman, I. Obsessive–compulsive disorder in children and adolescents. Paediatrics and Child Health. 2009 67-72.;19(2).
  18. Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):764-71. PubMed PMID: 3264280.
  19. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989 Nov;46(11):1006-11. PubMed PMID: 2684084.
  20. Wootton BM, Diefenbach GJ, Bragdon LB, Steketee G, Frost RO, Tolin DF. A contemporary psychometric evaluation of the Obsessive Compulsive Inventory-Revised (OCI-R). Psychol Assess. 2015 Sep;27(3):874-82. PubMed PMID: 25664634. Pubmed Central PMCID: 4530108.
  21. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52. PubMed PMID: 9183141.
  22. Foa EB, Coles M, Huppert JD, Pasupuleti RV, Franklin ME, March J. Development and validation of a child version of the obsessive compulsive inventory. Behav Ther. 2010 Mar;41(1):121-32. PubMed PMID: 20171333.
  23. Pinto A, Van Noppen B, Calvocoressi L. Development and preliminary psychometric evaluation of a self-rated version of the Family Accommodation Scale for Obsessive-Compulsive Disorder. Journal of obsessive-compulsive and related disorders. 2013 Oct 01;2(4):457-65. PubMed PMID: 24855596. Pubmed Central PMCID: 4024376.
  24. Booth BD, Friedman SH, Curry S, Ward H, Stewart SE. Obsessions of child murder: underrecognized manifestations of obsessive-compulsive disorder. J Am Acad Psychiatry Law. 2014;42(1):66-74. PubMed PMID: 24618521.
  25. Fernandez de la Cruz L, Rydell M, Runeson B, D'Onofrio BM, Brander G, Ruck C, et al. Suicide in obsessive-compulsive disorder: a population-based study of 36 788 Swedish patients. Mol Psychiatry. 2016 Jul 19. PubMed PMID: 27431293.
  26. Angelakis I, Gooding P, Tarrier N, Panagioti M. Suicidality in obsessive compulsive disorder (OCD): a systematic review and meta-analysis. Clin Psychol Rev. 2015 Jul;39:1-15. PubMed PMID: 25875222.
  27. Health NCCfM. Core interventions in the treatment of obsessive compulsive disorder and body dysmorphic disorder (a guideline from the National Institute for Health and Clinical Excellence National Health Service). Lodon: British Psychiatric Society and Royal College of Psychiatrists; 2006.
  28. Socialstyrelsen. Socialstyrelsen Nationella riktlinjer för vård vid depression och ångestsyndrom: Stöd för styrning och ledning. . Stockholm: Socialstyrelsen; 2010.
  29. van Balkom AJ, de Haan E, van Oppen P, Spinhoven P, Hoogduin KA, van Dyck R. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis. 1998 Aug;186(8):492-9. PubMed PMID: 9717867.
  30. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005 Jan;162(1):151-61. PubMed PMID: 15625214.
  31. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry. 2006 Jun;51(7):407-16. PubMed PMID: 16838822.
  32. Steketee G PT, Schemmel T. Obsessive compulsive disorder : the latest assessment and treatment strategies. Kansas City, MO:: Compact Clinicals; 2006.
  33. Renshaw KD, Chambless DL, Steketee G. The relationship of relatives' attributions to their expressed emotion and to patients' improvement in treatment for anxiety disorders. Behav Ther. 2006 Jun;37(2):159-69. PubMed PMID: 16942969.
  34. March JS, & Mulle, K. OCD in children and adolescents: A cognitive-behavioral treatment manual. u.o.: Guilford Press; 1998.
  35. NICE. Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. London: National Institute for Health and Clinical Excellence; 2005.
  36. van Westen M, Rietveld E, Figee M, Denys D. Clinical Outcome and Mechanisms of Deep Brain Stimulation for Obsessive-Compulsive Disorder. Current behavioral neuroscience reports. 2015;2(2):41-8. PubMed PMID: 26317062. Pubmed Central PMCID: 4544542.
  37. Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry. 2014 Nov 29;14:317. PubMed PMID: 25432131. Pubmed Central PMCID: 4262998.
  38. Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symtom structure of obsessive-compulsive disorder. Am J Psychiatry. 2008 Dec;165(12):1532-42. PubMed PMID: 18923068. Pubmed Central PMCID: 3972003.
  39. Foa EB, Simpson HB, Liebowitz MR, Powers MB, Rosenfield D, Cahill SP, et al. Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder. J Clin Psychiatry. 2013 May;74(5):464-9. PubMed PMID: 23759449. Pubmed Central PMCID: 3977336.
  40. Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA psychiatry. 2013 Nov;70(11):1190-9. PubMed PMID: 24026523. Pubmed Central PMCID: 3955365.
  41. Trevizol AP1, Shiozawa P, Cook IA, Sato IA, Kaku CB, Guimarães FB, Sachdev P, Sarkhel S, Cordeiro Q, Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis. J ECT. 2016 Dec;32(4):262-266.
Publicerad: 2017/05/11 Senast uppdaterad: